OpenAI Acquires Orchestra Bio for Rosalind Life Sciences Model
OpenAI acquired Orchestra Bio, a four-year-old startup whose AI agents handle drug-discovery operations such as clinical trial scheduling and finances. Terms were not disclosed; Orchestra had raised about $20 million. OpenAI says it will fold the team and technology into Rosalind, its life sciences model, and Rosalind Workbench, which it says Moderna and Novo Nordisk use.